Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia

Cited by (788)

Items 401–500 of 788

1. Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosis
   Katerina Placek, Michael G Benatar, Joanne Wuu, Evadnie Rampersaud, Laura Hennessy, Vivianna M. Van Deerlin, Murray Grossman, David John Irwin, Lauren B. Elman, Leo F. McCluskey et al. · 2020 · EMBO Molecular Medicine
2. Pathogenic Genome Signatures That Damage Motor Neurons in Amyotrophic Lateral Sclerosis
   Ali Yousefian-Jazi, YunHee Seol, Jieun Kim, Hannah L. Ryu, Jung-Hee Lee, Hoon Ryu · 2020 · Cells
3. The molecular pathogenesis of superoxide dismutase 1-linked ALS is promoted by low oxygen tension
   Isil Keskin, Elin Forsgren, Manuela Lehmann, Peter Munch Andersen, Thomas Brännström, Dale J. Lange, Matthis Synofzik, Ulrika Nordström, Per Zetterström, Stefan L. Marklund et al. · 2019 · Acta Neuropathologica
4. Neurodegenerative Diseases: New Hopes and Perspectives
   Mohammad Aadil Bhat, Suneela Sunil Dhaneshwar · 2023 · Current Molecular Medicine
5. Defects of Nutrient Signaling and Autophagy in Neurodegeneration
   Jon Ondaro, Haizea Hernández-Eguiazu, Maddi Garciandia-Arcelus, Raúl Loera‐Valencia, Laura Rodríguez-Gómez, Andrés Jiménez-Zúñiga, Julen Goikolea, Patricia Rodriguez‐Rodriguez, Javier Ruiz‐Martínez, Fermín Moreno et al. · 2022 · Frontiers in Cell and Developmental Biology
6. Brain-Specific Cytoskeletal Damage Markers in Cerebrospinal Fluid: Is There a Common Pattern between Amyotrophic Lateral Sclerosis and Primary Progressive Multiple Sclerosis?
   Ahmed Abdelhak, Andreas Junker, Johannes Brettschneider, Jan Kassubek, Albert Ludolph, Markus Otto, Hayrettin Tumani · 2015 · International Journal of Molecular Sciences
7. Conditional Deletion of CC2D1A Reduces Hippocampal Synaptic Plasticity and Impairs Cognitive Function through Rac1 Hyperactivation
   Cheng-Yi Yang, Ting-Hsuan Yu, Wan-Ling Wen, Pin Ling, Kuei‐Sen Hsu · 2019 · Journal of Neuroscience
8. Molecular Recognition of M1-Linked Ubiquitin Chains by Native and Phosphorylated UBAN Domains
   Lina Herhaus, Henry van den Bedem, Sean Tang, Innokentiy Maslennikov, Soichi Wakatsuki, Ivan Đikić, Simin Rahighi · 2019 · Journal of Molecular Biology
9. Analyses of the genetic diversity and protein expression variation of the acyl: CoA medium-chain ligases, ACSM2A and ACSM2B
   Rencia van der Sluis · 2018 · Molecular Genetics and Genomics
10. Review: Microglia in motor neuron disease
    Bridget Ashford, Delphine Boche, Johnathan Cooper‐Knock, Paul Roy Heath, Julie E. Simpson, J. Robin Highley · 2020 · Neuropathology and Applied Neurobiology
11. Study on sleep-wake disorders in patients with genetic and non-genetic amyotrophic lateral sclerosis
    Xiaohan Sun, Ximeng Zhao, Qing Liu, Shuangwu Liu, Kang Zhang, Zhili Wang, Xunzhe Yang, Liang Shang, Yan Huang, Liying Cui et al. · 2020 · Journal of Neurology Neurosurgery & Psychiatry
12. Cerebellar Kv3.3 potassium channels activate TANK-binding kinase 1 to regulate trafficking of the cell survival protein Hax-1
    Yalan Zhang, Luis Varela, Klara Szigeti‐Buck, Adam Williams, Milan Stoiljković, Matija Šestan-Peša, Jorge Henao‐Mejia, Pasquale D’Acunzo, Efrat Levy, Richard Anthony Flavell et al. · 2021 · Nature Communications
13. The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics
    Wenzhi Chen, Ling Guo, Manna Li, Caihui Wei, Shu Li, Renshi Xu · 2022 · Brain Research
14. Advances in sequencing technologies for amyotrophic lateral sclerosis research
    Evan Udine, Angita Jain, Marka van Blitterswijk · 2023 · Molecular Neurodegeneration
15. Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk prediction
    Oliver Pain, Ashley Jones, Ahmad Al Khleifat, Devika Agarwal, Dzmitry Hramyka, Hajer Karoui, Jędrzej Kubica, David J. Llewellyn, Janice M. Ranson, Zhi Yao et al. · 2024 · Heliyon
16. Protein Disulphide Isomerases: emerging roles of PDI and ERp57 in the nervous system and as therapeutic targets for ALS
    Emma R. Perri, Sonam Parakh, Julie D. Atkin · 2016 · Expert Opinion on Therapeutic Targets
17. Transgenic TBK1 mice have features of normal tension glaucoma
    John H. Fingert, Kathy Miller, Adam Hedberg‐Buenz, Ben R. Roos, Carly J. van der Heide, Robert F. Mullins, Michael G. Anderson · 2016 · Human Molecular Genetics
18. Frontotemporal dementia spectrum: first genetic screen in a Greek cohort
    Eliana Marisa Ramos, Christos Koros, Deepika Reddy Dokuru, Victoria Van Berlo, Christos Κroupis, Kevin J. Wojta, Qing Wang, Nikolaos Andronas, Stavroula Matsi, Ion Beratis et al. · 2018 · Neurobiology of Aging
19. Could sirtuin activities modify ALS onset and progression?
    Tang, Bor Luen · 2017 · Cellular and Molecular Neurobiology
20. Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencing
    Cyril P. Pottier, Fahri Küçükali, Matt C. Baker, Anthony J. Batzler, Gregory D. Jenkins, Marka van Blitterswijk, Cristina T. Vicente, Wouter De Coster, Sarah Wynants, Pieter Van de Walle et al. · 2025 · Nature Communications
21. Clinical variability and onset age modifiers in an extended Belgian GRN founder family
    Eline Wauters, Sara Van Mossevelde, Kristel Sleegers, Julie van der Zee, Sebastiaan Engelborghs, Anne Sieben, Rik R. Vandenberghe, Stéphanie Philtjens, Marleen Van den Broeck, Karin Peeters et al. · 2018 · Neurobiology of Aging
22. Why TDP-43? Why Not? Mechanisms of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis
    Mara-Luciana Floare, Scott P. Allen · 2020 · Neuroscience Insights
23. How Inflammation Pathways Contribute to Cell Death in Neuro-Muscular Disorders
    Sara Salucci, Anna Bartoletti Stella, Michela Battistelli, Sabrina Burattini, Alberto Bavelloni, Lucio Cocco, Pietro Gobbi, Irene Faenza · 2021 · Biomolecules
24. TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex
    Stephanie L. Rayner, Shu Yang, Natalie E. Farrawell, Cyril Jones Jagaraj, Flora Cheng, Jennilee M. Davidson, Luan Luu, Alberto García‐Redondo, Alberto Rábano, Daniel Borrego‐Hernández et al. · 2022 · Neurobiology of Disease
25. RIP kinases and necroptosis in aging and aging-related diseases
    Yuanxin Yang, Xingyan Li, Tao Zhang, Daichao Xu · 2022 · Life Medicine
26. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases
    Roberta Cascella, Giulia Fani, Alessandra Bigi, Fabrizio Chiti, Cristina Cecchi · 2019 · International Journal of Molecular Sciences
27. Genetic Testing for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
    Jennifer Roggenbuck, Jamie C Fong · 2020 · Clinics in Laboratory Medicine
28. Remodeling without destruction: non-proteolytic ubiquitin chains in neural function and brain disorders
    Alexis S. Zajicek, Wei‐Dong Yao · 2020 · Molecular Psychiatry
29. Neuroprotective activity of ursodeoxycholic acid in CHMP2B models of frontotemporal dementia
    Ryan J. H. West, Chris Ugbode, Laura Fort‐Aznar, Sean T. Sweeney · 2020 · Neurobiology of Disease
30. A TBK1 variant causes autophagolysosomal and motoneuron pathology without neuroinflammation in mice
    Dávid Brenner, Kirsten Sieverding, Jahnavi Srinidhi, Susanne Zellner, Christopher Secker, Rüstem Yilmaz, Julia Dyckow, Shady Amr, Anna Ponomarenko, Esra Tunaboylu et al. · 2024 · The Journal of Experimental Medicine
31. Amyotrophe Lateralsklerose
    Annemarie Hübers, Albert Christian Ludolph, Angela Rosenbohm, Elmar Hans Pinkhardt, Jochen Hans Weishaupt, Johannes Dorst · 2015 · Der Nervenarzt
32. Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship
    Niccolò Candelise, Illari Salvatori, Silvia Scaricamazza, Valentina Nesci, Henri Zenuni, Alberto Ferri, Cristiana Valle · 2022 · Metabolites
33. Recent Advances in Frontotemporal Dementia
    Maria Carmela Tartaglia, Ian R. Mackenzie · 2022 · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
34. Prospects for gene replacement therapies in amyotrophic lateral sclerosis
    Ilaria Giovannelli, Adrian Higginbottom, Janine Kirby, Mimoun Azzouz, Pamela J. Shaw · 2022 · Nature Reviews Neurology
35. Proteostasis and Ribostasis Impairment as Common Cell Death Mechanisms in Neurodegenerative Diseases
    Su Min Lim, Minyeop Nahm, Seung Hyun Kim · 2023 · Journal of Clinical Neurology
36. The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy
    Megan Fowler, Frances Theunissen, Jillian M. Carr, Mary‐Louise Rogers · 2023 · Molecular Neurobiology
37. Mitochondria-associated membrane collapse impairs TBK1-mediated proteostatic stress response in ALS
    Seiji Watanabe, Yuri Murata, Yasuyoshi Oka, Kotaro Oiwa, Mai Horiuchi, Yohei Iguchi, Okiru Komine, Akira Sobue, Masahisa Katsuno, Tomoo Ogi et al. · 2023 · Proceedings of the National Academy of Sciences
38. Regulation of TBK1 activity by Optineurin contributes to cell cycle-dependent expression of the interferon pathway
    Robert Weil, Emmanuel Laplantine, Pierre Génin · 2016 · Cytokine & Growth Factor Reviews
39. Genetic and functional analysis of TBK1 variants in Korean patients with sporadic amyotrophic lateral sclerosis
    Young-Eun Kim, Ki‐Wook Oh, Min‐Young Noh, Minyeop Nahm, Jinseok Park, Su Min Lim, Ja‐Hyun Jang, Eun‐Hae Cho, Chang‐Seok Ki, Seungbok Lee et al. · 2016 · Neurobiology of Aging
40. Optineurin Insufficiency Disbalances Proinflammatory and Anti-inflammatory Factors by Reducing Microglial IFN-β Responses
    Andrea Markovinović, Tereza Ljutić, Louis‐Charles Béland, Ivana Munitić · 2018 · Neuroscience
41. ALS Yeast Models—Past Success Stories and New Opportunities
    Sonja E. Di Gregorio, Martin L. Duennwald · 2018 · Frontiers in Molecular Neuroscience
42. Genetics of frontotemporal dementia in China
    Yaling Jiang, Bin Jiao, Xuewen Xiao, Lu Hua Shen · 2021 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
43. Mechanisms of TDP-43 Proteinopathy Onset and Propagation
    Han-Jou Chen, Jacqueline C. Mitchell · 2021 · International Journal of Molecular Sciences
44. Genetic architecture of motor neuron diseases
    Rishabh Chaudhary, Vipul Agarwal, Mujeeba Rehman, Arjun Singh Kaushik, Vikas Mishra · 2021 · Journal of the Neurological Sciences
45. Meta-analysis of Genetic Modifiers Reveals Candidate Dysregulated Pathways in Amyotrophic Lateral Sclerosis
    Katherine S. Yanagi, Zhijin J. Wu, Joshua Amaya, Natalie Chapkis, Amanda Duffy, Kaitlyn H. Hajdarovic, Aaron Held, Arjun D. Mathur, Kathryn Russo, Veronica H. Ryan et al. · 2018 · Neuroscience
46. Impact of single amino acid substitution on the structure and function of TANK‐binding kinase‐1
    Mohd Umair, Shama Khan, Taj Mohammad, Alaa Shafie, Farah Anjum, Asimul Islam, Md. Imtaiyaz Hassan · 2021 · Journal of Cellular Biochemistry
47. The prion-like nature of amyotrophic lateral sclerosis
    Luke McAlary, Justin J. Yerbury, Neil R. Cashman · 2020 · Progress in molecular biology and translational science
48. Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degenerations: Similarities in Genetic Background
    Eva Parobková, Radoslav Matěj · 2021 · Diagnostics
49. Mutant VAPB: Culprit or Innocent Bystander of Amyotrophic Lateral Sclerosis?
    Nica Borgese, Francesca Navone, Nobuyuki Nukina, Tomoyuki Yamanaka · 2021 · Contact
50. Protein network analysis to prioritize key genes in amyotrophic lateral sclerosis
    Rupesh Kumar, Shazia Haider · 2021 · IBRO Neuroscience Reports
51. Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis
    Wei‐Ming Su, Xiaojing Gu, Qing‐Qing Duan, Zheng Jiang, Xia Gao, Huifang Shang, Yongping Chen · 2022 · BMC Medicine
52. Emerging roles of TBK1 in cancer immunobiology
    Alex Miranda, Carl A. Shirley, Russell William Jenkins · 2024 · Trends in cancer
53. Frequency and characteristics of the TBK1 gene variants in Japanese patients with sporadic amyotrophic lateral sclerosis
    Genki Tohnai, Ryoichi Nakamura, Jun Sone, Masahiro Nakatochi, Daichi Yokoi, Masahisa Katsuno, Hazuki Watanabe, Hirohisa Watanabe, Mizuki Ito, Yuanzhe Li et al. · 2017 · Neurobiology of Aging
54. A biallelic mutation linksMYORGto autosomal-recessive primary familial brain calcification
    Yalda Forouhideh, Kathrin Müller, Wolfgang Philipp Ruf, Muhannad Assi, Tuncay Şeker, Ceren Tunca, Antje Knehr, Tim Matthias Strom, Martin Gorges, Falk Schradt et al. · 2018 · Brain
55. Genetic forms of frontotemporal lobar degeneration: Current diagnostic approach and new directions in therapeutic strategies
    Leila Sellami, Dario Saracino, Isabelle Le Ber · 2020 · Revue Neurologique
56. Mitophagy and iron: two actors sharing the stage in age-associated neuronal pathologies
    Alfonso Schiavi, Flavie Strappazzon, Natascia Ventura · 2020 · Mechanisms of Ageing and Development
57. High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines
    Serena Lattante, Giuseppe Marangi, Paolo Niccolò Doronzio, Amelia Conte, Giulia Bisogni, Marcella Zollino, Mario Sabatelli · 2020 · Genes
58. Screening for possible oligogenic pathogenesis in Chinese sporadic ALS patients
    Hang Zhang, Wanshi Cai, Siyu Chen, Jialong Liang, Zhanjun Wang, Yuting Ren, Wenxiu Liu, Xiaolan Zhang, Zhong Sheng Sun, Xusheng Huang · 2018 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
59. Mitochondrial damage triggers the concerted degradation of negative regulators of neuronal autophagy
    Bishal Basak, Erika L.F. Holzbaur · 2025 · Nature Communications
60. Functional and structural consequences of TBK1 missense variants in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
    Yuval Gurfinkel, Nicole Polain, Krushna Sonar, Penelope Angela Nice, Ricardo L. Mancera, Sarah Lyn Rea · 2022 · Neurobiology of Disease
61. Genomic and transcriptomic advances in amyotrophic lateral sclerosis
    Mafalda Rizzuti, Luca Sali, Valentina Melzi, Simone Scarcella, Gianluca Costamagna, Linda Ottoboni, Lorenzo Quetti, Lorenzo Brambilla, Dimitra A. Papadimitriou, Federico Verde et al. · 2023 · Ageing Research Reviews
62. Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis
    Yasuyuki Ohta, Genevieve Soucy, Daniel Phaneuf, Jean‐Nicolas Audet, François Gros‐Louis, Guy Armand Rouleau, Hélène Blasco, Philippe Corcia, Peter Munch Andersen, Frida Nordin et al. · 2016 · Human Molecular Genetics
63. Astrocytes in Motor Neuron Diseases
    Chiara F. Valori, Giulia Guidotti, Liliana Brambilla, Daniela Rossi · 2019 · Advances in experimental medicine and biology
64. Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature
    Imogen J. Swift, Martina Bocchetta, Hanya Benotmane, Ione Woollacott, Rachelle Shafei, Jonathan Daniel Rohrer · 2020 · Neurobiology of Aging
65. Further development of biomarkers in amyotrophic lateral sclerosis
    Hélène Blasco, Patrick Vourc’h, Pierre‐François Pradat, P. H. Gordon, Christian Robert Andres, Philippe Corcia · 2016 · Expert Review of Molecular Diagnostics
66. Rare TBK1 variants in patients with frontotemporal dementia and amyotrophic lateral sclerosis in a Chinese cohort
    Bin Jiao, Qiying Sun, Zhenhua Yuan, Junling Wang, Lin Zhou, Xinxiang Yan, Beisha Tang, Lu Hua Shen · 2018 · Translational Neurodegeneration
67. Investigating CCNF mutations in a Taiwanese cohort with amyotrophic lateral sclerosis
    Pei‐Chien Tsai, Yi‐Chu Liao, Po‐Lin Chen, Yuh‐Cherng Guo, Yinghao Chen, Kang‐Yang Jih, Kon‐Ping Lin, Bing‐Wen Soong, Ching-Paio Tsai, Yi‐Chung Lee · 2017 · Neurobiology of Aging
68. Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort
    Jan Verheijen, Julie van der Zee, Ilse Gijselinck, Tobi Van den Bossche, Lubina Dillen, Bavo Heeman, Estrella Gómez‐Tortosa, Albert Lladó, Raquel Sánchez‐Valle, Caroline Graff et al. · 2017 · Neurobiology of Aging
69. An FTLD-associated SQSTM1 variant impacts Nrf2 and NF-κB signalling and is associated with reduced phosphorylation of p62
    Adriana Foster, Daniel Scott, Robert Layfield, Sarah Lyn Rea · 2019 · Molecular and Cellular Neuroscience
70. Therapeutic targeting of TANK-binding kinase signaling towards anticancer drug development: Challenges and opportunities
    Manzar Alam, Md. Meraj Ansari, Saba Noor, Taj Mohammad, Gulam Mustafa Hasan, Syed Naqui Kazim, Md. Imtaiyaz Hassan · 2022 · International Journal of Biological Macromolecules
71. Neurodegenerative disorders of the human frontal lobes
    Paul Monroe Butler, Winston Chiong · 2019 · Handbook of clinical neurology
72. The pro-apoptotic JNK scaffold POSH/SH3RF1 mediates CHMP2BIntron5-associated toxicity in animal models of frontotemporal dementia
    Ryan J. H. West, Chris Ugbode, Fen‐Biao Gao, Sean T. Sweeney · 2018 · Human Molecular Genetics
73. Evaluation of a 5-HT2B receptor agonist in a murine model of amyotrophic lateral sclerosis
    Alizée Arnoux, Estelle Ayme‐Dietrich, Stéphane Dieterle, Marc-Antoine Goy, Stéphan Schann, Mélanie Frauli, Laurent Monassier, Luc Dupuis · 2021 · Scientific Reports
74. Genetic Variability of Inflammation and Oxidative Stress Genes Affects Onset, Progression of the Disease and Survival of Patients with Amyotrophic Lateral Sclerosis
    Metka Ravnik‐Glavač, Katja Goričar, David Vogrinc, Blaž Koritnik, Jakob Gašper Lavrenčič, Damjan Glavač, Vita Dolžan · 2022 · Genes
75. RNA Helicases in Microsatellite Repeat Expansion Disorders and Neurodegeneration
    Lydia M. Castelli, Bridget C. Benson, Wan-Ping Huang, Ya-Hui Lin, Guillaume M. Hautbergue · 2022 · Frontiers in Genetics
76. Fast versus slow disease progression in amyotrophic lateral sclerosis–clinical and genetic factors at the edges of the survival spectrum
    Simon Witzel, Matias Wagner, Chen Zhao, Katharina Kandler, Elisabeth Graf, Riccardo Berutti, Konrad Oexle, Dávid Brenner, Juliane Winkelmann, Albert Christian Ludolph · 2022 · Neurobiology of Aging
77. Molecular mechanisms of amyotrophic lateral sclerosis as broad therapeutic targets for gene therapy applications utilizing adeno‐associated viral vectors
    Jessica Merjane, Roger S. Chung, Rickie Patani, Leszek Lisowski · 2023 · Medicinal Research Reviews
78. Screening of the TBK1 gene in familial and sporadic amyotrophic lateral sclerosis patients of Chinese origin
    Shi Shu, Xiao Ling Li, Qing Fei Liu, Fang Liu, Bo Cui, Ming Sheng Liu, Liying Cui, Xiaoguang Li, Xue Zhang · 2016 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
79. A Chemical Screen Identifies Compounds Limiting the Toxicity of C9ORF72 Dipeptide Repeats
    Alba Corman, Bomi Jung, Maria Häggblad, Lars Bräutigam, Vanesa Lafarga, Louise Lidemalm, Daniela Hühn, Jordi Carreras Puigvert, Óscar Fernández-Capetillo · 2018 · Cell chemical biology
80. Neuropathological characterization of a novel TANK binding kinase (TBK1) gene loss of function mutation associated with amyotrophic lateral sclerosis
    M. Weinreich, Stephanie R. Shepheard, Nick S. Verber, Matthew Wyles, Paul Roy Heath, J. Robin Highley, Janine Kirby, Pamela J. Shaw · 2019 · Neuropathology and Applied Neurobiology
81. Identification of TYW3/CRYZ and FGD4 as susceptibility genes for amyotrophic lateral sclerosis
    Ling Wei, Yanghua Tian, Yongping Chen, Qianqian Wei, Fangfang Chen, Bei Cao, Ying Wu, Bi Zhao, Xueping Chen, Chengjuan Xie et al. · 2019 · Neurology Genetics
82. Ik2/TBK1 and Hook/Dynein, an adaptor complex for early endosome transport, are genetic modifiers of FTD-associated mutant CHMP2B toxicity in Drosophila
    Yubing Lu, Ryan J. H. West, Marine Pons, Sean T. Sweeney, Fen‐Biao Gao · 2020 · Scientific Reports
83. Immune Signaling Kinases in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD)
    Raquel García-García, Laura Martín-Herrero, Laura Blanca-Pariente, Jesús A. Pérez-Cabello, Cintia Roodveldt · 2021 · International Journal of Molecular Sciences
84. The paradigm of amyloid precursor protein in amyotrophic lateral sclerosis: The potential role of the 682 YENPTY 687 motif
    Carmela Matrone · 2023 · Computational and Structural Biotechnology Journal
85. Lysosomal TBK1 responds to amino acid availability to relieve Rab7-dependent mTORC1 inhibition
    Gabriel Talaia, Amanda Bentley‐DeSousa, Shawn M. Ferguson · 2024 · The EMBO Journal
86. Genetic spectrum features and diagnostic accuracy of four plasma biomarkers in 248 Chinese patients with frontotemporal dementia
    Tianyan Xu, Ling Weng, Cong Zhang, Xuewen Xiao, Qijie Yang, Yuan Zhu, Yafang Zhou, Xinxin Liao, Shilin Luo, Junling Wang et al. · 2024 · Alzheimer s & Dementia
87. The role of de novo mutations in the development of amyotrophic lateral sclerosis
    Perry T.C. van Doormaal, Nicola Ticozzi, Jochen Hans Weishaupt, Kevin Patrick Kenna, Frank P. Diekstra, Federico Verde, Peter Munch Andersen, Annelot M. Dekker, Cinzia Tiloca, Nicolai Marroquin et al. · 2017 · Human Mutation
88. Loss of TBK1 activity leads to TDP-43 proteinopathy through lysosomal dysfunction in human motor neurons
    Jin Hao, Michael F. Wells, Gengle Niu, Irune Guerra San Juan, Francesco Limone, Atsushi Fukuda, Marcel F. Leyton-Jaimes, Brian J. Joseph, Menglu Qian, Daniel A. Mordes et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
89. TIR immune signalling is blocked by phosphorylation to maintain plant growth
    Guojun Li, Sisi Chen, Bo Yu, Qingzhong Li, Ruijia Liu, Zaiqing Wang, Li Wan, Yang Zhao · 2025 · Nature Plants
90. Large-scale exome analyses reveal new rare variant contributions in amyotrophic lateral sclerosis
    Paul J. Hop, Maarten Kooyman, Brendan Kenna, Ramona A.J. Zwamborn, Kristel R. van Eijk, Yan Wang, Charlotte H. van Dijk, Erwin Bekema, Wouter van Rheenen, Paul Beele et al. · 2026 · Nature Genetics
91. The diverse role of optineurin in pathogenesis of disease
    Qingyi Guo, Jincheng Wang, Qinjie Weng · 2020 · Biochemical Pharmacology
92. Recent progress in small molecule TBK1 inhibitors: a patent review (2015– 2020)
    Douglas W. Thomson, Giovanna Bergamini · 2021 · Expert Opinion on Therapeutic Patents
93. Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis
    Mohamed F. El‐Mansy, Cory T. Reidl, Mizzanoor Rahaman, P. Hande Özdi̇nler, Richard B. Silverman · 2023 · Medicinal Research Reviews
94. Post-Translational Variants of Major Proteins in Amyotrophic Lateral Sclerosis Provide New Insights into the Pathophysiology of the Disease
    Léa Bedja-Iacona, Élodie Richard, Sylviane Marouillat, Céline Brulard, Tarek Alouane, S. Beltran, Christian Robert Andres, Hélène Blasco, Philippe Corcia, Charlotte Veyrat‐Durebex et al. · 2024 · International Journal of Molecular Sciences
95. ALS-associated C21ORF2 variant disrupts DNA damage repair, mitochondrial metabolism, neuronal excitability and NEK1 levels in human motor neurons
    Pavol Zelina, A.A. De Ruiter, Christy Kolsteeg, Ilona van Ginneken, Harmjan R. Vos, Laura. F. Supiot, Boudewijn M.T. Burgering, Frank Julius Meye, Jan Herman Veldink, Leonard H. van den Berg et al. · 2024 · Acta Neuropathologica Communications
96. Unraveling the multifaceted insights into amyotrophic lateral sclerosis: Genetic underpinnings, pathogenesis, and therapeutic horizons
    Ramaish Sharma, Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta, Acharan Singh Narula · 2024 · Mutation Research/Reviews in Mutation Research
97. Combined Pathologies in FTLD-TDP Types A and C
    Tamar D. Gefen, Saman Seyed Ahmadian, Qinwen Mao, Garam Kım, Mustafa Faik Seckin, Borna Bonakdarpour, Eliana Marisa Ramos, Giovanni Coppola, Rosa Rademakers, Emily Joy Rogalski et al. · 2018 · Journal of Neuropathology & Experimental Neurology
98. Tuning Apoptosis and Neuroinflammation: TBK1 Restrains RIPK1
    Haiyang Yu, Don W. Cleveland · 2018 · Cell
99. Immunological signatures in frontotemporal lobar degeneration
    Sirkis, Daniel W., Bonham, Luke W., Karch, Celeste M., Yokoyama, Jennifer S. · 2019 · Current Opinion in Neurology
100. The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)
     Jimmy Beckers, Philip Van Damme · 2025 · Autophagy Reports